This dual action of improving systemic insulin resistance and acting on brain insulin receptors makes GLP-1 RAs a unique treatment option for individuals with both conditions
JPM week rarely yields immediate outcomes, but it tends to set the terms for the next quarters conversations
the tirzepatide shortage in October 2024
administered 15 min before oral injection of d-allulose
In a Phase II trial, retatrutide demonstrated a mean weight reduction of over 17.5% in adults without diabetes but with obesity or pre-obesity, marking a significant advancement in weight management therapies
Now, chains are competing on nutrition, protein content, and smaller portion sizes, driven in large part by the growing number of customers using GLP-1 medications